e42 Nucleic Acids Research, 2008, Vol. 36, No. 7 5. Shi,H., Wang,M.X. and Caldwell,C.W. (2007) CpG islands: their potential as biomarkers for cancer. Expert Rev. Mol. Diagn., 7, 519–531. 6. Toyota,M. and Issa,J.P. (2005) Epigenetic changes in solid and hematopoietic tumors. Semin. Oncol., 32, 521–530. 7. Cottrell,S.E. and Laird,P.W. (2003) Sensitive detection of DNA methylation. Ann. NY Acad. Sci., 983, 120–130. 8. Palmisano,W.A., Divine,K.K., Saccomanno,G., Gilliland,F.D., Baylin,S.B., Herman,J.G. and Belinsky,S.A. (2000) Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res., 60, 5954–5958. 9. Chan,K.C. and Lo,Y.M. (2007) Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers. Br. J. Cancer, 96, 681–685. 10. Taback,B. and Hoon,D.S. (2004) Circulating nucleic acids and proteomics of plasma/serum: clinical utility. Ann. NY Acad. Sci., 1022, 1–8. 11. Herman,J.G., Graﬀ,J.R., Myohanen,S., Nelkin,B.D. and Baylin,S.B. (1996) Methylation-speciﬁc PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl Acad. Sci. USA, 93, 9821–9826. 12. Aggerholm,A. and Hokland,P. (2000) DAP-kinase CpG island methylation in acute myeloid leukemia: methodology versus biology? Blood, 95, 2997–2999. 13. Dobrovic,A. (2005) In Coleman,W.B. and Tsongalis,G.J. (eds), Molecular diagnostics for the clinical laboratorian, 2nd edn. Humana Press, Totowa, NJ, pp. 149–160. 14. Rand,K., Qu,W., Ho,T., Clark,S.J. and Molloy,P. (2002) Conversion-speciﬁc detection of DNA methylation using real-time polymerase chain reaction (ConLight-MSP) to avoid false positives. Methods, 27, 114–120. 15. Taylor,K.H., Kramer,R.S., Davis,J.W., Guo,J., Duﬀ,D.J., Xu,D., Caldwell,C.W. and Shi,H. (2007) Ultradeep bisulﬁte sequencing analysis of DNA methylation patterns in multiple gene promoters by 454 sequencing. Cancer Res., 67, 8511–8518. 16. Warnecke,P.M., Stirzaker,C., Song,J., Grunau,C., Melki,J.R. and Clark,S.J. (2002) Identiﬁcation and resolution of artifacts in bisulﬁte sequencing. Methods, 27, 101–107. 17. Ehrich,M., Zoll,S., Sur,S. and van den Boom,D. (2007) A new method for accurate assessment of DNA quality after bisulﬁte treatment. Nucleic Acids Res., 35, e29. 18. Sasaki,M., Anast,J., Bassett,W., Kawakami,T., Sakuragi,N. and Dahiya,R. (2003) Bisulﬁte conversion-speciﬁc and methylation-speciﬁc PCR: a sensitive technique for accurate evaluation of CpG methylation. Biochem. Biophys. Res. Commun., 309, 305–309. 19. Eads,C.A., Danenberg,K.D., Kawakami,K., Saltz,L.B., Blake,C., Shibata,D., Danenberg,P.V. and Laird,P.W. (2000) MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res., 28, E32. 20. Lo,Y.M., Wong,I.H., Zhang,J., Tein,M.S., Ng,M.H. and Hjelm,N.M. (1999) Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-speciﬁc polymerase chain reaction. Cancer Res., 59, 3899–3903. 21. Eads,C.A., Danenberg,K.D., Kawakami,K., Saltz,L.B., Danenberg,P.V. and Laird,P.W. (1999) CpG island hypermethyla- tion in human colorectal tumors is not associated with DNA methyltransferase overexpression. Cancer Res., 59, 2302–2306. 22. Gudnason,H., Dufva,M., Bang,D.D. and Wolﬀ,A. (2007) Comparison of multiple DNA dyes for real-time PCR: eﬀects of dye concentration and sequence composition on DNA ampliﬁcation and melting temperature. Nucleic Acids Res., 35, e127. 23. Miller,S.A., Dykes,D.D. and Polesky,H.F. (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res., 16, 1215. 24. Umetani,N., de Maat,M.F., Mori,T., Takeuchi,H. and Hoon,D.S. (2005) Synthesis of universal unmethylated control DNA by nested whole genome ampliﬁcation with phi29 DNA polymerase. Biochem. Biophys. Res. Commun., 329, 219–223. 25. Steger,G. (1994) Thermal denaturation of double-stranded nucleic acids: prediction of temperatures critical for gradient gel electrophoresis and polymerase chain reaction. Nucleic Acids Res, 22, 2760–2768. PAGE 12 OF 13 26. Livak,K.J. and Schmittgen,T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402–408. 27. Ogino,S., Kawasaki,T., Brahmandam,M., Cantor,M., Kirkner,G.J., Spiegelman,D., Makrigiorgos,G.M., Weisenberger,D.J., Laird,P.W., Loda,M. et al. (2006) Precision and performance characteristics of bisulﬁte conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J. Mol. Diagn., 8, 209–217. 28. Paz,M.F., Fraga,M.F., Avila,S., Guo,M., Pollan,M., Herman,J.G. and Esteller,M. (2003) A systematic proﬁle of DNA methylation in human cancer cell lines. Cancer Res., 63, 1114–1121. 29. Reinhold,W.C., Reimers,M.A., Maunakea,A.K., Kim,S., Lababidi,S., Scherf,U., Shankavaram,U.T., Ziegler,M.S., Stewart,C., Kouros-Mehr,H. et al. (2007) Detailed DNA methyla- tion proﬁles of the E-cadherin promoter in the NCI-60 cancer cells. Mol. Cancer Ther., 6, 391–403. 30. Wong,I.H., Ng,M.H., Lee,J.C., Lo,K.W., Chung,Y.F. and Huang,D.P. (1998) Transcriptional silencing of the p16 gene in human myeloma-derived cell lines by hypermethylation. Br. J. Haematol., 103, 168–175. 31. Dahl,C. and Guldberg,P. (2007) A ligation assay for multiplex analysis of CpG methylation using bisulﬁte-treated DNA. Nucleic Acids Res., 35, e144. 32. Feng,W., Shen,L., Wen,S., Rosen,D.G., Jelinek,J., Hu,X., Huan,S., Huang,M., Liu,J., Sahin,A.A. et al. (2007) Correlation between CpG methylation proﬁles and hormone receptor status in breast cancers. Breast Cancer Res., 9, R57. 33. Aggerholm,A., Guldberg,P., Hokland,M. and Hokland,P. (1999) Extensive intra- and interindividual heterogeneity of p15INK4B methylation in acute myeloid leukemia. Cancer Res., 59, 436–441. 34. Mikeska,T., Bock,C., El-Maarri,O., Hubner,A., Ehrentraut,D., Schramm,J., Felsberg,J., Kahl,P., Buttner,R., Pietsch,T. et al. (2007) Optimization of quantitative MGMT promoter methylation analysis using pyrosequencing and combined bisulﬁte restriction analysis. J. Mol. Diagn., 9, 368–381. 35. Dodge,J.E., List,A.F. and Futscher,B.W. (1998) Selective variegated methylation of the p15 CpG island in acute myeloid leukemia. Int. J. Cancer, 78, 561–567. 36. Tan,L.W., Bianco,T. and Dobrovic,A. (2002) Variable promoter region CpG island methylation of the putative tumor suppressor gene Connexin 26 in breast cancer. Carcinogenesis, 23, 231–236. 37. Cameron,E.E., Baylin,S.B. and Herman,J.G. (1999) p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing. Blood, 94, 2445–2451. 38. Chan,M.W., Chu,E.S., To,K.F. and Leung,W.K. (2004) Quantitative detection of methylated SOCS-1, a tumor suppressor gene, by a modiﬁed protocol of quantitative real time methylation- speciﬁc PCR using SYBR green and its use in early gastric cancer detection. Biotechnol Lett., 26, 1289–1293. 39. Chu,D.C., Chuang,C.K., Fu,J.B., Huang,H.S., Tseng,C.P. and Sun,C.F. (2002) The use of real-time quantitative polymerase chain reaction to detect hypermethylation of the CpG islands in the promoter region ﬂanking the GSTP1 gene to diagnose prostate carcinoma. J. Urol., 167, 1854–1858. 40. Hong,Y.S., Roh,M.S., Kim,N.Y., Lee,H.J., Kim,H.K., Lee,K.E., Kwak,J.Y. and Kim,J.Y. (2007) Hypermethylation of p16INK4a in Korean non-small cell lung cancer patients. J Korean Med. Sci., 22 (Suppl), S32–S37. 41. Thomassin,H., Kress,C. and Grange,T. (2004) MethylQuant: a sensitive method for quantifying methylation of speciﬁc cytosines within the genome. Nucleic Acids Res., 32, e168. 42. Zipper,H., Brunner,H., Bernhagen,J. and Vitzthum,F. (2004) Investigations on DNA intercalation and surface binding by SYBR Green I, its structure determination and methodological implications. Nucleic Acids Res., 32, e103. 43. Giglio,S., Monis,P.T. and Saint,C.P. (2003) Demonstration of preferential binding of SYBR Green I to speciﬁc DNA fragments in real-time multiplex PCR. Nucleic Acids Res., 31, e136. 44. Guldberg,P., Worm,J. and Gronbaek,K. (2002) Proﬁling DNA methylation by melting analysis. Methods, 27, 121–127.